These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¨
|
Preliminary Proxy Statement
|
|
|
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
|
|
ý
|
Definitive Proxy Statement
|
|
|
|
|
¨
|
Definitive Additional Materials
|
|
|
|
|
¨
|
Soliciting Material Pursuant to §240.14a-12
|
|
ý
|
No fee required.
|
|
|
|
|
|
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11
|
|
|
|
|
|
|
|
1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
|
|
|
4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
5)
|
Total fee paid:
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
|
|
|
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
|
|
1)
|
Amount Previously Paid:
|
|
|
|
|
|
|
2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
|
|
3)
|
Filing Party:
|
|
|
|
|
|
|
4)
|
Date Filed:
|
|
|
|
Sincerely,
|
|
|
|
Martin J. Vanderploeg
President, Chief Executive Officer and Director
|
|
1.
|
Elect three
Class II
directors for a three-year term;
|
|
2.
|
Approve, on an advisory basis, the compensation of our named executive officers;
|
|
3.
|
Indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers;
|
|
4.
|
Ratify the appointment of Ernst & Young LLP ("EY") as our independent registered public accounting firm for the fiscal year ending
December 31, 2019
; and
|
|
5.
|
Transact any other business as may properly come before the meeting or any adjournment or postponement thereof.
|
|
|
|
By Order of the Board of Directors
|
|
|
|
Troy M. Calkins
Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
1.
|
To elect
Martin J. Vanderploeg
,
Brigid A. Bonner
and
Suku Radia
as
Class II
directors for three-year terms;
|
|
2.
|
To approve, on an advisory basis, the compensation of our named executive officers, as described in this proxy statement;
|
|
3.
|
To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers;
|
|
4.
|
To ratify the appointment of EY as our independent registered public accounting firm for the fiscal year ending
December 31, 2019
; and
|
|
5.
|
To transact any other business as may properly come before the Annual Meeting or at any adjournment or postponement thereof.
|
|
•
|
"FOR" the election of
Martin J. Vanderploeg
,
Brigid A. Bonner
and
Suku Radia
as
Class II
directors;
|
|
•
|
"FOR" the approval, on an advisory basis, of the compensation of our named executive officers, as described in this proxy statement;
|
|
•
|
"FOR" holding an advisory vote on our executive compensation practices each year; and
|
|
•
|
"FOR" the ratification of the appointment of EY as our independent registered public accounting firm for the fiscal year ending
December 31, 2019
.
|
|
•
|
Via the Internet.
You may vote by proxy via the Internet by following the instructions found on the proxy card.
|
|
•
|
By Telephone.
You may vote by proxy by calling the toll-free number found on the proxy card.
|
|
•
|
By Mail.
You may vote by proxy by filling out the proxy card and returning it in the envelope provided.
|
|
•
|
In Person
. You may vote in person at the Annual Meeting. You must request a ballot when you arrive.
|
|
•
|
Via the Internet.
You may vote by proxy via the Internet by following the instructions on the voting instruction form provided to you by your broker, bank or other nominee.
|
|
•
|
By Telephone.
You may vote by proxy by calling the toll-free number found on the voting instruction form provided to you by your broker, bank or other nominee.
|
|
•
|
By Mail.
You may vote by proxy by filling out the voting instruction form and returning it in the envelope provided to you by your broker, bank or other nominee
.
|
|
•
|
In Person.
If you wish to vote in person, you must obtain a legal proxy from the organization that holds your shares. Please contact that organization for instructions on how to obtain a legal proxy to you from your broker, bank or other nominee.
|
|
•
|
Written notice to our Corporate Secretary;
|
|
•
|
Timely delivery of a valid, later-dated proxy or a later-dated vote by telephone or on the Internet; or
|
|
•
|
Voting in person at the Annual Meeting.
|
|
Proposal
|
Vote Required
|
Broker Discretionary Voting Allowed?
|
|
|
Election of directors
|
Plurality of votes cast
|
No
|
|
|
Advisory approval of the compensation of our named executive officers
|
Majority of votes cast
|
No
|
|
|
Advisory vote on the frequency of stockholder advisory votes on executive compensation
|
Plurality of votes cast
|
No
|
|
|
Ratification of appointment of independent registered public accounting firm
|
Majority of votes cast
|
Yes
|
|
|
Name
|
Age
|
Director Since
|
|
Class II Directors - Term Expiring at the 2019 Annual Meeting
|
||
|
Martin J. Vanderploeg, Ph.D.
|
62
|
December 2014
|
|
Brigid A. Bonner
|
58
|
October 2018
|
|
Suku Radia
|
67
|
December 2014
|
|
Class III Directors - Term Expiring at the 2020 Annual Meeting
|
||
|
Michael M. Crow, Ph.D.
|
63
|
December 2014
|
|
Eugene S. Katz
|
73
|
December 2014
|
|
Class I Directors - Term Expiring at the 2021 Annual Meeting
|
||
|
Robert H. Herz
|
65
|
December 2014
|
|
David S. Mulcahy
|
66
|
December 2014
|
|
•
|
Possess fundamental qualities of intelligence, honesty, perceptiveness, good judgment, maturity, high ethics and standards, integrity, fairness and responsibility.
|
|
•
|
Have a genuine interest in Workiva and recognition that as a member of our Board, each director is accountable to all of our stockholders, not to any particular interest group.
|
|
•
|
Have a background that demonstrates an understanding of business and financial affairs.
|
|
•
|
Have no conflict of interest or legal impediment that would interfere with the duty of loyalty owed to Workiva and our stockholders.
|
|
•
|
Have the ability and be willing to spend the time required to function effectively as a director.
|
|
•
|
Be compatible and able to work well with other directors and executives in a team effort with a view to a long-term relationship with Workiva as a director.
|
|
•
|
Have independent opinions and be willing to state them in a constructive manner.
|
|
•
|
appointment, termination, compensation and oversight of the work of any accounting firm engaged to prepare or issue an audit report or other audit, review or attest services;
|
|
•
|
considering and approving, in advance, all audit and non-audit services to be performed by independent accountants;
|
|
•
|
reviewing and discussing the adequacy and effectiveness of our accounting and financial reporting processes and controls and the audits of our financial statements;
|
|
•
|
establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or auditing matters and the confidential, anonymous submission by our employees of concerns regarding questionable accounting or auditing matters;
|
|
•
|
investigating any matter brought to its attention within the scope of its duties and engaging independent counsel and other advisers as the Audit Committee deems necessary;
|
|
•
|
determining compensation of the independent auditors, compensation of advisors hired by the Audit Committee and ordinary administrative expenses;
|
|
•
|
reviewing quarterly financial statements prior to their release;
|
|
•
|
reviewing and assessing the adequacy of a formal written charter on an annual basis;
|
|
•
|
reviewing and approving related-party transactions for potential conflict of interest situations on an ongoing basis; and
|
|
•
|
handling such other matters that are specifically delegated to the Audit Committee by our Board from time to time.
|
|
•
|
reviewing and approving the compensation and benefits of all of our executive officers and key employees;
|
|
•
|
monitoring and reviewing our compensation and benefit plans;
|
|
•
|
overseeing the activities of the individuals responsible for administering cash incentive compensation plans and equity-based plans; and
|
|
•
|
such other matters that are specifically delegated to the Compensation Committee by our Board from time to time.
|
|
•
|
evaluating and making recommendations regarding the organization and governance of our Board and its committees and changes to our Certificate of Incorporation and Bylaws and stockholder communications;
|
|
•
|
assessing the performance of Board members and making recommendations regarding committee and chair assignments and composition and the size of our Board and its committees;
|
|
•
|
reviewing proposed waivers of the code of conduct for directors and executive officers;
|
|
•
|
evaluating and making recommendations regarding the creation of additional committees or the change in mandate or dissolution of committees; and
|
|
•
|
reviewing succession planning for our executive officers and evaluating potential successors.
|
|
•
|
Audit Committee – $20,000 for the chair and $10,000 for each other member;
|
|
•
|
Compensation Committee – $15,000 for the chair and $7,500 for each other member; and
|
|
•
|
Nominating and Governance Committee – $10,000 for the chair and $5,000 for each other member.
|
|
Name
|
|
Fees Earned or Paid in Cash ($)
|
|
Stock Awards ($)
(1)
|
|
All Other Compensation ($)
|
|
Total ($)
|
||||
|
Brigid A. Bonner
(2)
|
|
10,632
|
|
|
200,000
|
|
(3)
|
—
|
|
|
210,632
|
|
|
Michael M. Crow, Ph.D.
|
|
75,842
|
|
|
185,000
|
|
(4)
|
—
|
|
|
260,842
|
|
|
Robert H. Herz
|
|
68,332
|
|
|
185,000
|
|
(4)
|
—
|
|
|
253,332
|
|
|
Eugene S. Katz
|
|
81,257
|
|
|
185,000
|
|
(4)
|
—
|
|
|
266,257
|
|
|
David S. Mulcahy
|
|
80,584
|
|
|
185,000
|
|
(4)
|
—
|
|
|
265,584
|
|
|
Suku Radia
|
|
74,606
|
|
|
185,000
|
|
(4)
|
—
|
|
|
259,606
|
|
|
(1)
|
As of
December 31, 2018
, no director held options other than Mr. Herz, who held an option to purchase 39,600 shares, which was fully vested as of that date. As of
December 31, 2018
, the aggregate number of unvested restricted stock units of Class A common stock for each director was as follows: Ms. Bonner:
5,926
shares; Dr. Crow:
7,034
shares; Mr. Herz:
7,034
shares; Mr. Katz:
7,034
shares; Mr. Mulcahy:
7,034
shares and Mr. Radia:
7,034
shares. Ms. Bonner, Dr. Crow, Mr. Mulcahy, Mr. Radia and Mr. Katz have each elected to defer all or a portion of the receipt of these shares.
|
|
(2)
|
Ms. Bonner became a director on October 30, 2018.
|
|
(3)
|
Represents the aggregate grant-date fair value of
5,926
shares of restricted stock units granted to our new non-employee director on October 30, 2018, calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification ("ASC") Topic 718. Restricted stock units vest fully on the first anniversary of the grant date. The grant-date fair value is based on $33.75 per share, the closing price of our Class A common stock on the grant date. The assumptions used in calculating the grant-date fair value of the awards reported in this column are set forth in Note 9 to our audited consolidated financial statements included in our Annual Report on Form 10-K filed on
February 20, 2019
.
|
|
(4)
|
Represents the aggregate grant-date fair value of 7,034 shares of restricted stock units granted to each non-employee director on
June 11, 2018
, calculated in accordance with ASC Topic 718. Restricted stock units vest fully on the first anniversary of the grant date. The grant-date fair value is based on $26.30 per share, the closing price of our Class A common stock on the grant date. The assumptions used in calculating the grant-date fair value of the awards reported in this column are set forth in Note 9 to our audited consolidated financial statements included in our Annual Report on Form 10‑K filed on
February 20, 2019
.
|
|
•
|
each beneficial owner of 5% or more of the outstanding shares of our Class A or Class B common stock;
|
|
•
|
each of our directors and director nominees;
|
|
•
|
each of our named executive officers; and
|
|
•
|
all directors, director nominees and executive officers as a group.
|
|
|
|
Shares Beneficially Owned
|
|
% of total voting power
|
||||||||
|
|
|
Class A Common Stock
|
|
Class B Common Stock
|
|
|||||||
|
Name of Beneficial Owner
|
|
Number
|
|
%
|
|
Number
|
|
%
|
|
|||
|
Named Executive Officers and Directors
:
|
|
|
|
|
|
|
|
|
|
|
||
|
Martin J. Vanderploeg, Ph.D.
(1)
|
|
920,090
|
|
|
2.5
|
|
3,328,651
|
|
|
35.3
|
|
26.2
|
|
J. Stuart Miller
(2)
|
|
244,736
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Troy M. Calkins
(3)
|
|
250,987
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Scott Ryan
(4)
|
|
140,625
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Jeffrey Trom, Ph.D.
(5)
|
|
276,222
|
|
|
*
|
|
2,633,665
|
|
|
27.9
|
|
20.4
|
|
Matthew M. Rizai, Ph.D.
(6)
|
|
1,448,421
|
|
|
4.0
|
|
2,512,395
|
|
|
26.7
|
|
20.4
|
|
Michael M. Crow, Ph.D.
(7)
|
|
52,875
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Robert H. Herz
(8)
|
|
107,910
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Eugene S. Katz
(9)
|
|
87,316
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
David S. Mulcahy
|
|
195,168
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Suku Radia
|
|
24,875
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
Brigid A. Bonner
|
|
—
|
|
|
*
|
|
—
|
|
|
*
|
|
*
|
|
All executive officers and directors as a group (12 persons)
(10)
|
|
2,372,218
|
|
|
6.4
|
|
5,962,316
|
|
|
63.3
|
|
47.2
|
|
5% Stockholders
:
|
|
|
|
|
|
|
|
|
|
|
||
|
T. Rowe Price Associates, Inc.
(11)
|
|
3,024,266
|
|
|
8.5
|
|
—
|
|
|
*
|
|
2.3
|
|
The Behar Living Trust
(12)
|
|
2,893,870
|
|
|
8.1
|
|
—
|
|
|
*
|
|
2.2
|
|
BlackRock, Inc.
(13)
|
|
2,317,883
|
|
|
6.5
|
|
—
|
|
|
*
|
|
1.8
|
|
The Vanguard Group
(14)
|
|
2,217,061
|
|
|
6.2
|
|
—
|
|
|
*
|
|
1.7
|
|
Matthew and Tonja Rizai Charitable Remainder Trust
(15)
|
|
—
|
|
|
*
|
|
489,113
|
|
|
5.2
|
|
3.8
|
|
(*)
|
Represents beneficial ownership of less than 1% of class.
|
|
(1)
|
Shares owned consist of
328,402
shares of Class B common stock owned by the Jeffrey Dean Trom Charitable Remainder Trust, of which Mr. Vanderploeg is trustee;
400,000
shares of Class A common stock and
2,515,009
shares of Class B common stock owned by the Martin J. Vanderploeg 2001 Revocable Living Trust, of which Mr. Vanderploeg is trustee;
485,240
shares of Class B common stock and
40,000
shares of Class A common stock owned by the LAURA C WILLIAMS TR UA 05/02/2001, of which Laura Williams is the trustee, has sole dispositive power to such shares and has entered into an irrevocable proxy under which she has granted sole voting power to Mr. Vanderploeg for so long as the trust holds such shares; and
480,090
shares of Class A common stock subject to outstanding options that are exercisable within 60 days. The Martin J. Vanderploeg 2001 Revocable Living Trust has pledged
400,000
shares of the Class A common stock to secure a line of credit.
|
|
(2)
|
Shares owned consist of
24,489
shares of Class A common stock owned directly by Mr. Miller and
220,247
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(3)
|
Shares owned consist of
36,180
shares of Class A common stock owned directly by Mr. Calkins and
214,807
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(4)
|
Shares owned consist of
140,625
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(5)
|
Shares owned consist of
60,000
shares of Class A common stock owned directly by Mr. Trom;
140,000
shares of Class B common stock owned directly by Mr. Trom;
1,604,645
shares of Class B common stock owned by the Jeffrey D. Trom & Lydia A. Trom TR UA 11/21/2017;
889,020
shares of Class B common stock owned by the Martin J. Vanderploeg Charitable Remainder Trust, of which Mr. Trom is trustee; and
216,222
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(6)
|
Shares owned consist of
66,585
shares of Class A common stock and
32,783
shares of Class B common stock owned directly by Mr. Rizai;
575,000
shares of Class A common stock and
1,292,058
shares of Class B common stock owned by the Matthew Rizai TR UA DTD 03/04/1996 Matthew Rizai Revocable Trust, of which Mr. Rizai is the trustee;
885,109
shares of Class B common stock owned by Mr. Rizai and Svetlana Skopcenko as trustees u/a dated August 7, 2013 creating Marital Trust, of which Mr. Rizai has sole voting power and Mr. Rizai and Ms. Skopcenko have shared dispositive power;
546,825
shares of Class A common stock subject to outstanding options that are exercisable within 60 days;
260,011
shares of Class A common stock subject to deferred restricted units distributable within 60 days; and
302,445
shares of Class B common stock owned by family trusts of which Barbara Schlaff is the trustee and has entered into an irrevocable proxy under which she has granted sole voting power to Mr. Rizai for so long as the family trusts hold such shares. Ms. Schlaff has sole dispositive power as to such shares. The Matthew Rizai TR UA DTD 03/04/1996 Matthew Rizai Revocable Trust has pledged
542,217
shares of Class A common stock to secure a loan and a line of credit.
|
|
(7)
|
Shares owned consist of
52,875
shares of Class A common stock owned by the Michael M. Crow and Sybil Francis Family Trust, of which Dr. Crow and Mrs. Francis are trustees and have shared voting and investment power.
|
|
(8)
|
Shares owned consist of
53,356
shares of Class A common stock owned directly by Mr. Herz;
7,920
shares of Class A common stock owned jointly with Mr. Herz's spouse;
7,034
shares of Class A common stock subject to restricted stock units distributable within 60 days; and
39,600
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(9)
|
Shares owned consist of
87,116
shares of Class A common stock owned directly by Mr. Katz and
200
shares of Class A common stock owned by Mr. Katz's spouse.
|
|
(10)
|
The aggregate share amount shown includes
1,383,005
shares of Class A common stock subject to outstanding options that are exercisable within 60 days.
|
|
(11)
|
Based on information provided in a Schedule 13G filed with the SEC on February 14, 2019 by T. Rowe Price Associates, Inc. and T. Rowe Price New Horizons Fund, Inc. T. Rowe Price Associates Inc. has sole voting power with respect to
428,011
shares and sole dispositive power with respect to
3,024,266
shares, and T. Rowe Price New Horizons Fund has sole voting power with respect to
2,534,050
shares. The address for T. Rowe Price Associates, Inc. is 100 E. Pratt Street, Baltimore, MD, 21202.
|
|
(12)
|
Shares owned consist of
3,065
shares of Class A common stock held by Mr. and Dr. Behar's minor son and
2,890,805
shares of Class A common stock held directly by The Behar Living Trust, of which Jerome M. Behar and Leslie F. Behar are co-trustees. Mr. and Dr. Behar have shared voting and dispositive power over all shares held by their minor son and The Behar Living Trust.
|
|
(13)
|
Based on information provided in a Schedule 13G filed with the SEC on February 8, 2019 by BlackRock, Inc. BlackRock, Inc. has sole voting power with respect to
2,182,213
shares and sole dispositive power with respect to
2,317,883
shares. The address for BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.
|
|
(14)
|
Based on information provided in a Schedule 13G/A filed with the SEC on February 11, 2019 by The Vanguard Group. The Vanguard Group has sole voting power with respect to
58,507
shares, shared voting power with respect to
2,467
shares, sole dispositive power with respect to
2,159,361
shares and shared dispositive power with respect to
57,700
shares. According to this filing, (i) Vanguard Fiduciary Trust Company, a wholly-owned subsidiary of The Vanguard Group, Inc. and a registered investment adviser, is the beneficial owner of
55,233
shares as a result of its serving as investment manager of collective trust accounts, and (ii) Vanguard Investments Australia, Ltd., a wholly-owned subsidiary of The Vanguard Group, Inc. and a registered investment adviser, is the beneficial owner of
5,741
shares as a result of its serving as investment manager of Australian investment offerings. The address for The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.
|
|
(15)
|
Shares owned consist of
489,113
shares of Class B common stock owned by the Matthew and Tonja Rizai Charitable Remainder Trust, of which Barbara Schlaff is the trustee.
|
|
Name
|
|
Title
|
|
Martin J. Vanderploeg, Ph.D.
|
|
Chief Executive Officer and President ("CEO")
|
|
J. Stuart Miller
|
|
Executive Vice President and Chief Financial Officer
|
|
Troy M. Calkins
|
|
Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
|
|
Scott Ryan
|
|
Executive Vice President and Chief Revenue Officer
|
|
Jeffrey Trom, Ph.D.
|
|
Executive Vice President and Chief Technology Officer
|
|
Matthew M. Rizai, Ph.D.
|
|
Former Chairman and Chief Executive Officer
|
|
•
|
Revenue for
2018
was
$244.3 million
, an increase of
17.5%
compared with
$207.9 million
in the prior year. Subscription and support revenue was
$200.4 million
, an increase of
18.4%
on a year-over-year basis.
|
|
•
|
Net cash provided by operating activities was
$6.4 million
in
2018
, compared to net cash provided by operating activities of
$5.5 million
in
2017
.
|
|
•
|
At
December 31, 2018
, 3,340 organizations subscribed to our Wdesk platform as compared to 3,063 at
December 31, 2017
.
|
|
•
|
Our subscription and support revenue retention rate remained above 96% at
December 31, 2018
.
|
|
•
|
We began converting existing customer orders to, and signing new orders primarily based on, a solution-based licensing model, which we believe is easier to scale, drives wider adoption and opens more markets for our platform.
|
|
•
|
Stockholders make a significant, direct financial investment in the company. This investment is essential to the company’s ongoing operations. These investors expect a return on that investment. This return should be delivered within the context of an appropriate risk/reward profile.
|
|
•
|
The company also makes a substantial investment in the form of the total compensation provided to its executives and looks for a corresponding return in growth and financial performance.
|
|
•
|
Executives desire a compensation opportunity that provides a high level of perceived value, so compensation arrangements need to be flexible to meet their financial and career-related needs.
|
|
•
|
Attract, motivate and retain employees at the executive level who contribute to our long-term success;
|
|
•
|
Provide an overall compensation opportunity to our executives that is competitive, rewards the achievement of our business objectives and effectively aligns executive officers’ interests with those of our stockholders;
|
|
•
|
Motivate our executives to achieve key strategic performance measures by linking incentive award opportunities to the achievement of performance objectives and by providing a portion of total compensation for executive officers in the form of ownership in our company through our equity compensation program; and
|
|
•
|
Promote teamwork while also recognizing the individual role each executive officer plays in our success.
|
|
•
|
No tax gross-ups on severance or change of control payments;
|
|
•
|
Golden parachute policy;
|
|
•
|
Compensation recoupment ("clawback") policy;
|
|
•
|
Anti-hedging and anti-pledging policy;
|
|
•
|
No option repricing without stockholder consent;
|
|
•
|
Strong emphasis on performance-based compensation;
|
|
•
|
Regular reviews of executive compensation and peer group data;
|
|
•
|
A work culture that fosters a focus on long-term value creation supported by tools that help executives to reach and maintain meaningful levels of individual share ownership;
|
|
•
|
Annual risk assessments;
|
|
•
|
No pension plans or Supplemental Executive Retirement Plans;
|
|
•
|
Limited perquisites for executives;
|
|
•
|
No guaranteed bonuses; and
|
|
•
|
No discounted stock options or SARs.
|
|
Element
|
|
Form
|
|
Purpose
|
|
Base Salary
|
|
Cash (fixed)
|
|
Provides a competitive level of pay that reflects the executive’s experience, role and responsibilities
|
|
Short-Term Incentives
|
|
Cash (variable)
|
|
Rewards achievement of corporate financial and strategic results for the year
|
|
Long-Term Incentives
|
|
Equity (variable)
|
|
Creates an ownership culture that provides meaningful incentives for management to drive stockholder value creation and supports our retention strategy
|
|
•
|
Each NEO’s role and responsibilities;
|
|
•
|
How the NEO is performing those responsibilities;
|
|
•
|
Our historical and anticipated future financial performance;
|
|
•
|
Compensation practices of a group of comparable public companies (where appropriate); and
|
|
•
|
The need to retain highly qualified executives in a competitive SaaS market for leadership talent.
|
|
•
|
Assisted in the development of the compensation market data we used to understand market competitive compensation practices;
|
|
•
|
Reviewed and assessed our compensation practices and the cash and equity compensation levels of our executive officers (including an equity retention analysis and change in control analysis), including our NEOs, and also for members of our Board of Directors;
|
|
•
|
Reviewed and assessed our current compensation programs to determine any changes that may need to be implemented in order to remain competitive with the market, as well as conducting an equity burn rate and overhang analysis;
|
|
•
|
Reviewed and assessed our current severance and change in control benefits against peer practices;
|
|
•
|
Advised on regulatory developments relating to executive compensation; and
|
|
•
|
Collaborated on the risk assessment relating to employee compensation.
|
|
Alteryx, Inc.
|
Cloudera, Inc.
|
Q2 Holdings, Inc.
|
|
AppFolio, Inc.
|
Coupa Software Incorporated
|
Rapid7, Inc.
|
|
Apptio, Inc.
|
FireEye, Inc.
|
RingCentral, Inc.
|
|
Aspen Technology, Inc.
|
HubSpot, Inc.
|
Smartsheet
|
|
Avalara, Inc.
|
Imperva, Inc.
|
Twilio, Inc.
|
|
Benefitfocus, Inc.
|
New Relic, Inc.
|
Zendesk, Inc.
|
|
BlackLine, Inc.
|
Paycom Software, Inc.
|
Zuora, Inc.
|
|
Box, Inc.
|
Paylocity Holding Corporation
|
|
|
•
|
A comparison to the base salaries paid by the companies in our compensation peer group;
|
|
•
|
The overall compensation that each executive may potentially receive during his or her employment with us; and
|
|
•
|
Internal parity considerations with respect to the base salaries of other executives who are comparably situated in terms of reporting structure and level of responsibility.
|
|
•
|
Base salaries for our 2017 NEOs had not been increased in the past two years, (
i.e.
, 2016 and 2017);
|
|
•
|
The need to better balance cash and equity compensation consistent with our compensation strategy as we move from "Emerging Growth Company" status;
|
|
•
|
The additional responsibilities assumed by certain of our NEOs as part of their role as a member of the senior management team; and
|
|
•
|
The need to retain a highly qualified executive management team that can provide the leadership necessary for our near-term and long-term success.
|
|
Name and Principal Position
|
|
2018 Base Salary ($)
|
|
2017 Base Salary ($)
|
|
Martin J. Vanderploeg, Ph.D.
President and Chief Executive Officer
|
|
690,000
|
|
550,000
|
|
J. Stuart Miller
Executive Vice President and Chief Financial Officer
|
|
400,000
|
|
375,000
|
|
Troy M. Calkins
Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
|
|
400,000
|
|
375,000
|
|
Scott Ryan
Executive Vice President and Chief Revenue Officer
|
|
450,000
|
|
350,000
|
|
Jeffrey D. Trom, Ph.D.
Executive Vice President and Chief Technology Officer
|
|
450,000
|
|
350,000
|
|
Matthew M. Rizai
Former Chairman and Chief Executive Officer
|
|
690,000
|
|
550,000
|
|
•
|
Revenue growth
|
|
•
|
Non-GAAP operating loss
|
|
•
|
Operating cash flow
|
|
Performance Metric
|
|
Target
|
|
Weighting
|
|||
|
Revenue Growth
|
|
13.3
|
%
|
|
60
|
%
|
|
|
Non-GAAP Operating Loss
|
|
$
|
(33,998
|
)
|
|
20
|
%
|
|
Operating Cash Flow
|
|
$
|
8,733
|
|
|
20
|
%
|
|
Name and Principal Position
|
|
2018 Target Bonus
|
|
|
Martin J. Vanderploeg, Ph.D.
President and Chief Executive Officer
|
|
200
|
%
|
|
J. Stuart Miller
Executive Vice President and Chief Financial Officer
|
|
75
|
%
|
|
Troy M. Calkins
Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
|
|
75
|
%
|
|
Scott Ryan
Executive Vice President and Chief Revenue Officer
|
|
100
|
%
|
|
Jeffrey D. Trom, Ph.D.
Executive Vice President and Chief Technology Officer
|
|
75
|
%
|
|
Matthew M. Rizai
Former Chairman and Chief Executive Officer
|
|
200
|
%
|
|
|
|
|
|
Threshold
|
|
Target
|
|
Maximum
|
||||
|
Performance
|
|
<80
|
%
|
|
80
|
%
|
|
100
|
%
|
|
>120
|
%
|
|
Payout
|
|
—
|
%
|
|
50
|
%
|
|
100
|
%
|
|
150
|
%
|
|
Performance Metric
|
|
Target
|
|
Actual Results
|
|
Achievement of Target
|
|
|||||
|
Revenue Growth
|
|
13.3
|
%
|
|
17.5
|
%
|
|
131.6
|
%
|
|
||
|
Non-GAAP Operating Loss
|
|
$
|
(33,998
|
)
|
|
$
|
(13,041
|
)
|
|
161.6
|
%
|
|
|
Operating Cash Flow
|
|
$
|
8,733
|
|
|
$
|
13,000
|
|
|
148.9
|
%
|
(1)
|
|
(1)
|
As adjusted to exclude cash severance paid to our former Chief Executive Officer.
|
|
Executive
|
|
2018 Base Salary ($)
|
|
2018 Target Bonus ($)
|
|
2018 Target Bonus (%)
|
|
2018 Calculated Bonus ($)
|
|
2018 Approved Bonus Payout ($)
|
|
Approved Bonus Payout as a % of Base Salary
|
||||||
|
Martin J. Vanderploeg, Ph.D.
|
|
690,000
|
|
|
1,380,000
|
|
|
200
|
%
|
|
2,070,000
|
|
|
1,104,000
|
|
|
160
|
%
|
|
J. Stuart Miller
|
|
400,000
|
|
|
300,000
|
|
|
75
|
%
|
|
450,000
|
|
|
360,000
|
|
|
90
|
%
|
|
Troy M. Calkins
|
|
400,000
|
|
|
300,000
|
|
|
75
|
%
|
|
450,000
|
|
|
360,000
|
|
|
90
|
%
|
|
Scott Ryan
|
|
450,000
|
|
|
450,000
|
|
|
100
|
%
|
|
675,000
|
|
|
540,000
|
|
|
120
|
%
|
|
Jeffrey D. Trom, Ph.D.
|
|
450,000
|
|
|
337,500
|
|
|
75
|
%
|
|
506,250
|
|
|
405,000
|
|
|
90
|
%
|
|
•
|
RSUs help us better manage potential dilution to shareholders since they require fewer shares to provide the same date of grant value to employees.
|
|
•
|
RSUs are more valued by our employees than stock options because they have value at the date of grant.
|
|
•
|
RSUs are more consistent with the ownership culture we have created at Workiva.
|
|
•
|
RSUs are simpler to communicate to employees because the grant value is based on the current stock price rather than complex Black-Scholes or binomial calculations.
|
|
•
|
RSUs mitigate the potential inherent risk that can be associated with stock options.
|
|
•
|
No annual salary adjustments for NEOs in 2019.
|
|
•
|
Adjusting the amount and mix of total compensation for Mr. Vanderploeg to reflect his new role as President and CEO. These changes will include an increase in equity compensation along with a reduction in his 2019 Short-Term Incentive Plan target (to 125% of base salary).
|
|
COMPENSATION COMMITTEE
|
|
|
|
Mr. Suku Radia (Chair)
|
|
Ms. Brigid A. Bonner
|
|
Dr. Michael M. Crow, Ph.D.
|
|
Mr. David S. Mulcahy
|
|
Name and Principal Position
|
|
Year
|
|
Salary
($)
|
|
Bonus
($)
|
|
Stock Awards
($)
(1)
|
|
Option Awards
($)
(2)
|
|
Non-Equity Incentive Plan Compensation
($)
|
|
All Other Compensation
($)
|
|
|
Total
($)
|
||||||
|
Martin J. Vanderploeg, Ph.D.
|
|
2018
|
|
690,000
|
|
|
—
|
|
|
1,980,873
|
|
|
—
|
|
|
1,104,000
|
|
|
52,424
|
|
(3)
|
|
3,827,297
|
|
President, Chief Executive Officer and Director
|
|
2017
|
|
550,000
|
|
|
—
|
|
|
1,241,262
|
|
|
1,103,670
|
|
|
925,000
|
|
|
26,766
|
|
|
|
3,846,698
|
|
|
2016
|
|
550,000
|
|
|
475,000
|
|
|
1,241,263
|
|
|
1,107,621
|
|
|
—
|
|
|
400
|
|
|
|
3,374,284
|
|
|
J. Stuart Miller
|
|
2018
|
|
400,000
|
|
|
—
|
|
|
3,799,989
|
|
|
—
|
|
|
360,000
|
|
|
13,875
|
|
(4)
|
|
4,573,863
|
|
Executive Vice President and Chief Financial Officer
|
|
2017
|
|
375,000
|
|
|
—
|
|
|
695,763
|
|
|
206,215
|
|
|
375,000
|
|
|
150
|
|
|
|
1,652,127
|
|
|
2016
|
|
375,000
|
|
|
195,000
|
|
|
695,769
|
|
|
206,956
|
|
|
—
|
|
|
100
|
|
|
|
1,472,825
|
|
|
Troy M. Calkins
|
|
2018
|
|
400,000
|
|
|
—
|
|
|
3,250,013
|
|
|
—
|
|
|
360,000
|
|
|
14,146
|
|
(5)
|
|
4,024,159
|
|
Executive Vice President, Chief Legal and Administrative Officer and Corporate Secretary
|
|
2017
|
|
375,000
|
|
|
—
|
|
|
695,763
|
|
|
206,215
|
|
|
375,000
|
|
|
150
|
|
|
|
1,652,127
|
|
|
2016
|
|
375,000
|
|
|
195,000
|
|
|
695,769
|
|
|
206,956
|
|
|
—
|
|
|
100
|
|
|
|
1,472,825
|
|
|
Scott Ryan
|
|
2018
|
|
450,000
|
|
|
—
|
|
|
3,999,994
|
|
|
—
|
|
|
540,000
|
|
|
13,564
|
|
(6)
|
|
5,003,557
|
|
Executive Vice President and Chief Revenue Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Jeffrey Trom, Ph.D.
|
|
2018
|
|
416,667
|
|
|
—
|
|
|
4,550,003
|
|
|
—
|
|
|
405,000
|
|
|
20,311
|
|
(7)
|
|
5,391,981
|
|
Executive Vice President and Chief Technology Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Matthew M. Rizai, Ph.D. (8)
|
|
2018
|
|
325,244
|
|
|
—
|
|
|
1,980,873
|
|
|
—
|
|
|
—
|
|
|
6,731,883
|
|
|
|
9,037,999
|
|
Former Chairman and Chief Executive Officer
|
|
2017
|
|
550,000
|
|
|
—
|
|
|
1,241,262
|
|
|
1,103,670
|
|
|
925,000
|
|
|
26,307
|
|
|
|
3,846,239
|
|
|
2016
|
|
550,000
|
|
|
475,000
|
|
|
1,241,263
|
|
|
1,107,621
|
|
|
—
|
|
|
400
|
|
|
|
3,374,284
|
|
|
(1)
|
The amounts reported are computed in accordance with FASB ASC Topic 718 based on the closing price of our Class A common stock on the date of grant. These amounts do not reflect the actual economic value that may ultimately be realized by the NEOs.
|
|
(2)
|
The amounts reported reflect the grant date fair value of the stock options granted to the NEOs as computed in accordance with FASB ASC Topic 718. The fair value of each option grant is estimated based on the fair market value on the date of grant using the Black-Scholes option pricing model. The assumptions that we used to calculate these amounts are discussed in Note 9 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2018
, and incorporated by reference herein. As required by SEC rules, the amounts shown exclude the impact of estimated forfeitures related to service-based vesting conditions.
|
|
(3)
|
Includes $51,694 of premiums paid for supplemental disability insurance, as well as entertainment costs related to our annual sales retreat and annual service award payable to all employees.
|
|
(4)
|
Includes $13,675 of premiums paid for supplemental disability insurance, as well as an annual service award payable to all employees.
|
|
(5)
|
Includes $13,294 of premiums paid for supplemental disability insurance, as well as entertainment costs related to our annual sales retreat and an annual service award payable to all employees.
|
|
(6)
|
Includes $12,819 of premiums paid for supplemental disability insurance, as well as entertainment costs related to our annual sales retreat and an annual service award payable to all employees.
|
|
(7)
|
Includes $19,811 of premiums paid for supplemental disability insurance, as well as an annual service award payable to all employees.
|
|
(8)
|
Mr. Rizai's fiscal 2018 salary reflects a partial year of service. Pursuant to a separation agreement, all other compensation includes $6,620,548 in separation costs, $79,615 paid for accrued but unused paid time off, $22,277 of premiums paid for supplemental disability insurance and $8,721in COBRA payments, as well as entertainment costs related to our annual sales retreat.
|
|
|
|
|
|
|
Estimated Possible Payouts Under Non-Equity Incentive Plan Awards
(1)
|
|
All Other Stock Awards: Number of Shares of Stock or Units
(#)
(3)
|
|
Grant Date Fair Value of Stock Awards
($)
(4)
|
|||||||||
|
Name
|
Grant Date
(2)
|
|
Award Date
(2)
|
|
Threshold
($)
|
|
Target
($)
|
|
Maximum
($)
|
|
|
|||||||
|
Martin J. Vanderploeg, Ph.D.
|
02/01/2018
|
(5)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
89,028
|
|
|
1,980,873
|
|
|
02/16/2018
|
|
|
|
690,000
|
|
|
1,380,000
|
|
|
2,070,000
|
|
|
—
|
|
|
—
|
|
|
|
J. Stuart Miller
|
02/01/2018
|
(5)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
35,955
|
|
|
799,999
|
|
|
|
02/01/2018
|
(6)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
134,831
|
|
|
2,999,990
|
|
|
|
02/16/2018
|
|
|
|
150,000
|
|
|
300,000
|
|
|
450,000
|
|
|
—
|
|
|
—
|
|
|
Troy M. Calkins
|
02/01/2018
|
(5)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,708
|
|
|
750,003
|
|
|
|
02/01/2018
|
(6)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
112,360
|
|
|
2,500,010
|
|
|
|
02/16/2018
|
|
|
|
150,000
|
|
|
300,000
|
|
|
450,000
|
|
|
—
|
|
|
—
|
|
|
Scott Ryan
|
02/01/2018
|
(5)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
35,955
|
|
|
799,999
|
|
|
|
02/01/2018
|
(6)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
143,820
|
|
|
3,199,995
|
|
|
|
02/16/2018
|
|
|
|
225,000
|
|
|
450,000
|
|
|
675,000
|
|
|
—
|
|
|
—
|
|
|
Jeffrey D. Trom, Ph.D.
|
02/01/2018
|
(5)
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
33,708
|
|
|
750,003
|
|
|
|
02/16/2018
|
|
|
|
168,750
|
|
|
337,500
|
|
|
506,250
|
|
|
—
|
|
|
—
|
|
|
|
09/04/2018
|
(6)
|
8/28/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
100,000
|
|
|
3,800,000
|
|
|
Former Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Matthew M. Rizai, Ph.D.
|
02/01/2018
|
|
1/15/2018
|
|
—
|
|
|
—
|
|
|
—
|
|
|
89,028
|
|
|
1,980,873
|
|
|
|
02/16/2018
|
|
|
|
690,000
|
|
|
1,380,000
|
|
|
2,070,000
|
|
|
—
|
|
|
—
|
|
|
(1)
|
Represents awards made pursuant to our 2018 Short-Term Incentive Plan. Actual payouts under this plan were determined by the Compensation Committee applying negative discretion to the payouts indicated by the plan based on our 2018 performance. See "
Compensation Discussion and Analysis
-
Executive Compensation Program Elements
-
Non-Equity Incentive Plan Compensation
" for further discussion of our 2018 Short-Term Incentive Plan and the payouts thereunder.
|
|
(2)
|
The Compensation Committee approved annual equity awards at the January 2018 Compensation Committee meeting and an additional equity award on August 28, 2018 for Mr. Trom. In accordance with our equity award grant practices, the grant date is the first trading day of the month following the month in which grants are approved.
|
|
(3)
|
Represents awards of restricted stock units granted pursuant to our 2014 Equity Incentive Plan.
|
|
(4)
|
Reflects the aggregate grant date fair value determined in accordance with FASB ASC Topic 718 based on the closing price of our Class A common stock on the date of grant.
|
|
(5)
|
Vests in three equal annual installments beginning on February 1, 2019, subject to the individual’s continued service with us through each vesting date.
|
|
(6)
|
Vests in a single installment on February 1, 2021, subject to the individual’s continued service with us through the vesting date.
|
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||||||||
|
Name
|
|
Option/Stock Award Grant Date
|
|
Number of Securities Underlying Unexercised Options (#) Exercisable
|
|
Number of Securities Underlying Unexercised Options (#) Unexercisable
|
|
Option Exercise Price
($)
|
|
Option Expiration Date
|
|
Number of Shares or Units of Stock That Have Not Vested
(#)
|
|
Market Value of Shares or Units of Stock That Have Not Vested
($)
(1)
|
||||
|
Martin J. Vanderploeg, Ph.D.
|
|
08/12/2014
|
(2)
|
178,200
|
|
|
—
|
|
|
15.83
|
|
08/11/2024
|
|
—
|
|
|
—
|
|
|
|
01/19/2016
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
26,608
|
|
|
954,961
|
|
|
|
|
|
02/01/2016
|
(4)
|
112,281
|
|
|
56,140
|
|
|
14.74
|
|
01/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
01/18/2017
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
62,219
|
|
|
2,233,040
|
|
|
|
|
02/01/2017
|
(4)
|
66,735
|
|
|
133,469
|
|
|
12.40
|
|
01/31/2027
|
|
|
|
—
|
|
|
|
|
|
02/01/2018
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
89,028
|
|
|
3,195,215
|
|
|
J. Stuart Miller
|
|
04/07/2014
|
(5)
|
164,240
|
|
|
—
|
|
|
15.86
|
|
04/06/2024
|
|
—
|
|
|
—
|
|
|
|
|
08/12/2014
|
(2)
|
39,600
|
|
|
—
|
|
|
15.83
|
|
08/11/2024
|
|
—
|
|
|
—
|
|
|
|
|
01/19/2016
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
14,915
|
|
|
535,299
|
|
|
|
|
02/01/2016
|
(4)
|
20,979
|
|
|
10,490
|
|
|
14.74
|
|
01/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
01/18/2017
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
34,875
|
|
|
1,251,664
|
|
|
|
|
02/01/2017
|
(4)
|
12,469
|
|
|
24,938
|
|
|
12.40
|
|
01/31/2027
|
|
—
|
|
|
—
|
|
|
|
|
02/01/2018
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
35,955
|
|
|
1,290,425
|
|
|
|
|
02/01/2018
|
(6)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
134,831
|
|
|
4,839,085
|
|
|
Troy M. Calkins
|
|
02/25/2014
|
(7)
|
108,900
|
|
|
—
|
|
|
15.86
|
|
02/24/2024
|
|
—
|
|
|
—
|
|
|
|
|
03/27/2014
|
(7)
|
9,900
|
|
|
—
|
|
|
15.86
|
|
03/26/2024
|
|
—
|
|
|
—
|
|
|
|
|
08/12/2014
|
(2)
|
39,600
|
|
|
—
|
|
|
15.83
|
|
08/11/2024
|
|
—
|
|
|
—
|
|
|
|
|
01/19/2016
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
14,915
|
|
|
535,299
|
|
|
|
|
02/01/2016
|
(4)
|
20,979
|
|
|
10,490
|
|
|
14.74
|
|
01/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
01/18/2017
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
34,875
|
|
|
1,251,664
|
|
|
|
|
02/01/2017
|
(4)
|
12,469
|
|
|
24,938
|
|
|
12.40
|
|
01/31/2027
|
|
—
|
|
|
—
|
|
|
|
|
02/01/2018
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
33,708
|
|
|
1,209,780
|
|
|
|
|
02/01/2018
|
(6)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
112,360
|
|
|
4,032,600
|
|
|
Scott Ryan
|
|
09/01/2016
|
(8)
|
112,500
|
|
|
87,500
|
|
|
17.92
|
|
08/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
01/03/2017
|
(5)
|
21,875
|
|
|
28,125
|
|
|
13.55
|
|
01/02/2027
|
|
—
|
|
|
—
|
|
|
|
|
02/01/2018
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
35,955
|
|
|
1,290,425
|
|
|
|
|
02/01/2018
|
(6)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
143,820
|
|
|
5,161,700
|
|
|
Jeffrey D. Trom, Ph.D.
|
|
08/12/2014
|
(2)
|
178,200
|
|
|
—
|
|
|
15.83
|
|
08/11/2024
|
|
—
|
|
|
—
|
|
|
|
01/19/2016
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
10,054
|
|
|
360,838
|
|
|
|
|
|
02/01/2016
|
(4)
|
14,141
|
|
|
7,071
|
|
|
14.74
|
|
01/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
01/18/2017
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
23,509
|
|
|
843,738
|
|
|
|
|
02/01/2017
|
(4)
|
8,405
|
|
|
16,810
|
|
|
12.40
|
|
01/31/2027
|
|
—
|
|
|
—
|
|
|
|
|
02/01/2018
|
(3)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
33,708
|
|
|
1,209,780
|
|
|
|
|
09/04/2018
|
(6)
|
—
|
|
|
—
|
|
|
—
|
|
—
|
|
100,000
|
|
|
3,589,000
|
|
|
Matthew M. Rizai, Ph.D.
|
|
08/12/2014
|
|
178,200
|
|
|
—
|
|
|
15.83
|
|
08/11/2024
|
|
—
|
|
|
—
|
|
|
|
02/01/2016
|
|
168,421
|
|
|
—
|
|
|
14.74
|
|
01/31/2026
|
|
—
|
|
|
—
|
|
|
|
|
|
02/01/2017
|
|
200,204
|
|
|
—
|
|
|
12.40
|
|
01/31/2027
|
|
—
|
|
|
—
|
|
|
(1)
|
The market value of unvested stock awards is based on the closing market price of our Class A common stock on
December 31, 2018
of
$35.89
.
|
|
(2)
|
Vests as to 25% of the shares on August 1, 2015 and as to 6.25% of the shares at the end of each three-month period thereafter.
|
|
(3)
|
Award of restricted stock units that vest in three equal annual installments commencing on the first anniversary of the grant date. Each of the NEOs has elected to defer settlement of the restricted stock units pursuant to the Workiva Inc. Nonqualified Deferred Compensation Plan.
|
|
(4)
|
Vests in three equal annual installments commencing on the first anniversary of the grant date.
|
|
(5)
|
Vests as to 25% of the shares on the first anniversary of the grant date and as to 6.25% of the shares at the end of each three-month period thereafter.
|
|
(6)
|
Award of restricted stock units that vest in a single installment on February 1, 2021. Each of the NEOs has elected to defer settlement of the restricted stock units pursuant to the Workiva Inc. Nonqualified Deferred Compensation Plan.
|
|
(7)
|
Vests as to 25% of the shares on February 17, 2015 and as to 6.25% of the shares at the end of each three-month period thereafter.
|
|
(8)
|
Vests as to 25% of the shares on August 15, 2017 and as to 6.25% of the shares at the end of each three-month period thereafter.
|
|
|
Option Awards
|
|
Stock Awards
|
||||||||
|
Name
|
Number of Shares Acquired on Exercise
(#)
|
|
Value Realized on Exercise
($)
(1)
|
|
Number of Shares Acquired on Vesting
(#)
(2)
|
|
Valued Realized on Vesting
($)
(3)
|
||||
|
Martin J. Vanderploeg, Ph.D.
|
—
|
|
|
—
|
|
|
111,050
|
|
|
2,440,650
|
|
|
J. Stuart Miller
|
10,000
|
|
|
194,828
|
|
(4)
|
52,352
|
|
|
1,149,876
|
|
|
Troy M. Calkins
|
—
|
|
|
—
|
|
|
52,352
|
|
|
1,149,876
|
|
|
Scott Ryan
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Jeffrey D. Trom, Ph.D.
|
—
|
|
|
—
|
|
|
35,140
|
|
|
771,813
|
|
|
Matthew M. Rizai, Ph.D.
|
—
|
|
|
—
|
|
|
288,905
|
|
|
7,038,202
|
|
|
(1)
|
The value realized on exercise is calculated as the difference between the fair market value of our Class A common stock on the date of exercise and the applicable exercise price of those options.
|
|
(2)
|
The amounts reflected in this column include the following shares issuable pursuant to restricted stock units that vested in 2018, but were deferred pursuant to our Non-Qualified Deferred Compensation Plan: Mr. Vanderploeg,
55,614
shares; Mr. Miller,
30,880
shares; Mr. Calkins,
30,613
shares; Mr. Trom,
20,410
shares; and Mr. Rizai,
233,403
shares. As elected by the NEO, the receipt of these shares has been deferred until the earlier of an elected future settlement date or the employee’s separation from service with Workiva in accordance with Code Section 409A.
|
|
(3)
|
The value realized upon vesting is equal to the number of shares vesting multiplied by the closing market price of our Class A common stock on the vesting date.
|
|
(4)
|
Option exercise was completed at the direction and for the benefit of Mr. Miller's former spouse pursuant to a qualified domestic relations order.
|
|
Name
|
|
Executive Contributions
($)
(1)
|
|
Aggregate Earnings
($)
(2)
|
|
Aggregate Withdrawal/Distributions
($)
|
|
Aggregate Balance at December 31, 2018
($)
(3)
|
||||
|
Martin J. Vanderploeg, Ph.D.
|
|
1,218,637
|
|
|
1,162,900
|
|
|
—
|
|
|
2,950,948
|
|
|
J. Stuart Miller
|
|
676,689
|
|
|
647,712
|
|
|
—
|
|
|
1,643,583
|
|
|
Troy M. Calkins
|
|
670,848
|
|
|
643,971
|
|
|
—
|
|
|
1,634,000
|
|
|
Scott Ryan
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
Jeffrey Trom, Ph.D.
|
|
447,291
|
|
|
430,907
|
|
|
—
|
|
|
1,093,353
|
|
|
Matthew M. Rizai, Ph.D.
|
|
5,814,744
|
|
|
2,947,639
|
|
|
—
|
|
|
9,331,795
|
|
|
(1)
|
The reported dollar values are calculated by multiplying the number of deferred restricted stock units that vested in
2018
by the closing price of our Class A common stock on the date the respective restricted stock units vested. Contributions by Messrs. Vanderploeg, Miller, Calkins, Ryan, and Trom are not included in the Summary Compensation Table for the current fiscal year. The aggregate grant date fair value of the fully vested deferred restricted stock units included in this column that has been reported in the Summary Compensation Table as compensation for the current fiscal year is
$1,980,873
for Mr. Rizai.
|
|
(2)
|
Reflects earnings on shares deferred upon the vesting of restricted stock units, which consisted solely of stock price appreciation of the NEO's deferred restricted stock units during
2018
. These earnings are not included in the Summary Compensation Table.
|
|
(3)
|
Amount represents the cumulative value of the NEO's deferral activities, including earnings thereon as of
December 31, 2018
. The reported dollar values are calculated by multiplying the number of deferred restricted stock units held by the NEO as of
December 31, 2018
by the closing price of our Class A common stock on
December 31, 2018
. Includes the following amounts that have been reported as Stock Awards in the Summary Compensation Table for a prior fiscal year: Mr. Vanderploeg,
$1,211,484
; Mr. Miller,
$675,093
; Mr. Calkins,
$671,324
; and Mr. Rizai,
$4,432,690
.
|
|
•
|
any action by the NEO while employed by us involving willful gross misconduct having a material adverse effect on the Company;
|
|
•
|
the NEO’s willful failure to perform his duties (other than any such failure resulting from incapacity due to physical or mental illness); or
|
|
•
|
the NEO being convicted of (a) a felony under the laws of the United States or any state or (b) a felony under the laws of any other country or political subdivision thereof involving moral turpitude.
|
|
•
|
a reduction in the NEO's base salary without the NEO’s consent, other than a general reduction in base salary that affects all similarly situated executives in substantially the same proportions;
|
|
•
|
a material reduction in the NEO's target bonus opportunity from any target bonus opportunity in effect for the prior fiscal year without the NEO’s consent;
|
|
•
|
a relocation of the NEO's principal place of employment by more than 50 miles without the NEO’s written consent;
|
|
•
|
a material, adverse change in the NEO’s title, authority, duties or responsibilities (other than temporarily while the NEO’s is physically or mentally incapacitated or as required by applicable law) without the NEO’s written consent; or
|
|
•
|
a material adverse change in the reporting structure applicable to the NEO without the NEO’s written consent.
|
|
•
|
one person (or more than one person acting as a group) acquires beneficial ownership of the Company's voting securities that, together with the voting securities held by such person or group, constitutes more than 50% of the total fair market value or total voting power of the Company’s then outstanding voting securities;
|
|
•
|
one person (or more than one person acting as a group) acquires (or has acquired during the twelve-month period ending on the date of the most recent acquisition) beneficial ownership of the Company's voting securities possessing 30% or more of the total voting power of the Company’s then outstanding voting securities;
|
|
•
|
a majority of the members of our Board of Directors is replaced during any twelve-month period by directors whose appointment or election is not endorsed by a majority of our Board of Directors before the date of appointment or election; or
|
|
•
|
the sale of all or substantially all of the Company's assets.
|
|
Named Executive Officer
|
Compensation
|
Termination on Death or Disability ($)
|
|
Termination without Cause or for Good Reason ($)
|
|
Termination Without Cause or for Good Reason in connection with a Change in Control ($)
|
|||
|
Martin J. Vanderploeg, Ph.D.
|
Cash Severance
(1)
|
2,995,000
|
|
|
7,135,000
|
|
|
7,590,000
|
|
|
Option Acceleration
(3)
|
4,322,548
|
|
|
4,322,548
|
|
|
4,322,548
|
|
|
|
RSU Acceleration
(4)
|
6,383,216
|
|
|
6,383,216
|
|
|
6,383,216
|
|
|
|
Benefit Continuation
(5)
|
—
|
|
|
35,604
|
|
|
35,604
|
|
|
|
Total
|
13,700,764
|
|
|
17,876,368
|
|
|
18,331,368
|
|
|
|
|
|
|
|
|
|
|
|||
|
J. Stuart Miller
|
Cash Severance
(2)
|
1,075,000
|
|
|
1,775,000
|
|
|
2,400,000
|
|
|
Option Acceleration
(3)
|
807,657
|
|
|
807,657
|
|
|
807,657
|
|
|
|
RSU Acceleration
(4)
|
7,916,473
|
|
|
7,916,473
|
|
|
7,916,473
|
|
|
|
Benefit Continuation
(5)
|
—
|
|
|
10,643
|
|
|
10,643
|
|
|
|
Total
|
9,799,130
|
|
|
10,509,773
|
|
|
11,134,773
|
|
|
|
|
|
|
|
|
|
|
|||
|
Troy M. Calkins
|
Cash Severance
(2)
|
1,075,000
|
|
|
1,775,000
|
|
|
2,400,000
|
|
|
Option Acceleration
(3)
|
807,657
|
|
|
807,657
|
|
|
807,657
|
|
|
|
RSU Acceleration
(4)
|
7,029,344
|
|
|
7,029,344
|
|
|
7,029,344
|
|
|
|
Benefit Continuation
(5)
|
—
|
|
|
23,484
|
|
|
23,484
|
|
|
|
Total
|
8,912,001
|
|
|
9,635,485
|
|
|
10,260,485
|
|
|
|
|
|
|
|
|
|
|
|||
|
Scott Ryan
|
Cash Severance
(2)
|
1,350,000
|
|
|
2,250,000
|
|
|
3,150,000
|
|
|
Option Acceleration
(3)
|
2,200,688
|
|
|
2,200,688
|
|
|
2,200,688
|
|
|
|
RSU Acceleration
(4)
|
6,452,125
|
|
|
6,452,125
|
|
|
6,452,125
|
|
|
|
Benefit Continuation
(5)
|
—
|
|
|
35,578
|
|
|
35,578
|
|
|
|
Total
|
10,002,813
|
|
|
10,938,391
|
|
|
11,838,391
|
|
|
|
|
|
|
|
|
|
|
|||
|
Jeffrey Trom, Ph.D.
|
Cash Severance
(2)
|
1,137,500
|
|
|
1,925,000
|
|
|
2,700,000
|
|
|
Option Acceleration
(3)
|
544,419
|
|
|
544,419
|
|
|
544,419
|
|
|
|
RSU Acceleration
(4)
|
6,003,356
|
|
|
6,003,356
|
|
|
6,003,356
|
|
|
|
Benefit Continuation
(5)
|
—
|
|
|
35,604
|
|
|
35,604
|
|
|
|
Total
|
7,685,275
|
|
|
8,508,379
|
|
|
9,283,379
|
|
|
|
(1)
|
Mr. Vanderploeg will receive cash severance representing the sum of (a) base salary and (b) target bonus, and a pro rata bonus payment based on the bonus received in the preceding calendar year if his employment is terminated because of death or disability. If termination is without cause or for good reason, Mr. Vanderploeg will receive cash severance equal to (a) three times the sum of base salary and target bonus, plus (b) a pro rata bonus payment based on the bonus received in the preceding calendar year. If he experiences a qualifying termination in connection with a change in control, Mr. Vanderploeg will receive cash severance equal to (a) three times the sum of base salary and target bonus, plus (b) an amount equal to his target bonus for that fiscal year.
|
|
(2)
|
Mr. Miller, Mr. Calkins, Mr. Ryan, and Mr. Trom will receive cash severance representing the sum of (a) base salary and (b) target bonus, and a pro rata bonus payment based on the bonus received in the preceding calendar year if his employment is terminated because of death or disability. If termination is without cause or for good reason, Mr. Miller, Mr. Calkins, Mr. Ryan, and Mr. Trom will receive cash severance equal to (a) two times the sum of base salary and target bonus, plus (b) a pro rata bonus payment based on the bonus received in the preceding calendar year. If he experiences a qualifying termination in connection with a change in control, Mr. Miller, Mr. Calkins, Mr. Ryan, and Mr. Trom will receive cash severance equal to (a) three times the sum of base salary and target bonus, plus (b) an amount equal to his target bonus for that fiscal year.
|
|
(3)
|
These amounts represent the value of unvested options to purchase shares of our common stock that were held by the NEO at the end of fiscal 2018 and whose vesting would be accelerated. The value was calculated by multiplying the number of shares subject to the option whose vesting was accelerated by the difference between the closing market price of our stock on
December 31, 2018
and the applicable option exercise price. For more information regarding the
|
|
(4)
|
These amounts represent the value of restricted stock units that were held by the NEO at the end of fiscal 2018 and whose vesting would be accelerated. The value was calculated by multiplying the number of restricted stock units whose vesting was accelerated by the closing market price of our stock on
December 31, 2018
. For more information regarding the number of unvested restricted stock units held by each of the NEOs, see the table under the caption "
Outstanding Equity Awards at Fiscal Year-End
."
|
|
(5)
|
Represents 18 months of COBRA benefits in the case of termination without cause or a termination of employment for good reason within the change in control period.
|
|
Plan Category
|
|
Number of Securities to be Issued upon Exercise of Outstanding Options, Warrants and Rights
(2)
|
|
Weighted Average Exercise Price of Outstanding Options ($)
(2)(3)
|
|
Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans
(4)
|
|
Equity Compensation Plans Approved By Stockholders
(1)
|
|
9,314,057
|
|
13.65
|
|
7,912,604
|
|
Total
|
|
9,314,057
|
|
13.65
|
|
7,912,604
|
|
(1)
|
Consists of options to purchase
2,812,457
shares of Class A common stock under the 2009 Plan, options to purchase
3,587,718
shares of Class A common stock under the 2014 Plan, and
2,913,882
shares of our Class A common stock subject to restricted stock units under our 2014 Plan.
|
|
(2)
|
Does not include purchase rights under our ESPP as the purchase price and number of shares to be purchased under our ESPP are not determined until the end of the relevant purchase period.
|
|
(3)
|
Excludes restricted stock units because they have no exercise price.
|
|
(4)
|
Consists of
3,091,981
shares of Class A common stock available for issuance under our 2014 Plan and
4,820,623
shares of Class A common stock available for issuance under our ESPP.
|
|
•
|
we have been or are to be a participant;
|
|
•
|
the amount involved exceeded or exceeds $120,000; and
|
|
•
|
any of our directors, executive officers or holders of more than five percent of our capital stock, or any immediate family member of or person sharing the household with any of these individuals, had or will have a direct or indirect material interest.
|
|
|
|
|
|
|
|
Eugene S. Katz (Chair)
Robert H. Herz
David S. Mulcahy
Suku Radia
|
|
|
|
2018
|
|
2017
|
||||
|
Audit Fees
(1)
|
|
$
|
757,687
|
|
|
$
|
835,327
|
|
|
Audit-Related Fees
|
|
—
|
|
|
—
|
|
||
|
Tax Fees
|
|
—
|
|
|
—
|
|
||
|
All Other Fees
|
|
—
|
|
|
—
|
|
||
|
(1)
|
Audit fees consist of fees billed for professional services rendered in connection with the audit of our annual financial statements, review of our quarterly financial statements, and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements for those fiscal years.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|